搜索筛选:
搜索耗时7.1040秒,为你在为你在102,285,761篇论文里面共找到 5 篇相符的论文内容
发布年度:
Comparing overall survival between first generation EGFR-TKIs and chemotherapy in lung cancer patien
[期刊论文] 作者：Wei Deng,Yuanyuan Lei,Siyang Liu,Jinji Yang,Haiyan Tu,Honghong Yan,Yilong Wu,,
来源：Chinese Journal of Cancer Research 年份：2016
Objective: Combined overall survival(OS) analysis of Lux-Lung 3 and Lux-Lung 6 demonstrated that patients with epidermal growth factor receptor(EGFR) exon 19 de...
An exploratory study on the optimal chemotherapy regimen for NSCLC patients with EGFR common mutatio
[会议论文] 作者：xuewu wei,Yunting He,Ee KE,Haiyan Tu,Jinji Yang,Wenzhao Zhong,Xuchao Zhang,Yilong Wu,Qing Zhou,
来源：2019中国肿瘤学大会 年份：2019
Objective EGFR-TKIs have been the first-line treatment for advanced non-small cell lung cancer patients with EGFR mutations.Chemotherapy remains the standard treatment for patients without T790M mutat...
Molecular alterations in cerebrospinal fluid predict clinical outcomes of central nervous system met
[会议论文] 作者：Meimei zheng,Yangsi Li,Benyuan Jiang,Haiyan Tu,Junyi Ye,Jinji Yang,Xuchao Zhang,Shannon Chuai,Hao Sun,
来源：2019中国肿瘤学大会 年份：2019
Objective Brain metastases(BM)occurs in up to 44%of non-small-cell lung cancer(NSCLC)patients and are associated with a poor prognosis with a median overall survival 4–15 months in treated patients....
Predictive and prognostic value of de novo MET expression in patients with advanced non-small cell l
[会议论文] 作者：Anna Li,Feiyu Niu,Jinji Yang,Xuchao Zhang,Qing Zhou,Jian Su,Zhi Xie,Nana Lou,Jiefei Han,Huajun Chen,Haiyan Tu,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
Objective: The cellular-mesenchymal-epithelial transition protein (MET) has recently been identified as a novel promising target in non-small-cell lung canc...
Predictive and prognostic value of de novo MET expression in patients with advanced non-small cell l
[会议论文] 作者：Anna Li,Feiyu Niu,Jinji Yang,Xuchao Zhang,Qing Zhou,Jian Su,Zhi Xie,Nana Lou,Jiefei Han,Huajun Chen,Haiyan Tu,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
Objective: The cellular-mesenchymal-epithelial transition protein (MET) has recently been identified as a novel promising target in non-small-cell lung cancer (NSCLC) treatment....
相关搜索：
